These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 26198373)
21. Combination chemotherapy of gemcitabine and vinorelbine for patients in stage IIIB-IV non-small cell lung cancer: a phase II study of the West Japan Thoracic Oncology Group (WJTOG) 9908. Katakami N; Sugiura T; Nogami T; Yamamoto H; Negoro S; Nakano T; Okamoto N; Takada Y; Kodama K; Ariyoshi Y Lung Cancer; 2004 Jan; 43(1):93-100. PubMed ID: 14698543 [TBL] [Abstract][Full Text] [Related]
22. Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network. Hainsworth JD; Burris HA; Billings FT; Bradof JE; Baker M; Greco FA Cancer; 2001 Nov; 92(9):2391-8. PubMed ID: 11745295 [TBL] [Abstract][Full Text] [Related]
23. A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC). Ginopoulos P; Mastronikolis NS; Giannios J; Karana A; Siabi V; Karvelas F; Rathossis S; Apostolopoulos N; Mastorakou A Lung Cancer; 1999 Jan; 23(1):31-7. PubMed ID: 10100144 [TBL] [Abstract][Full Text] [Related]
24. [Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)]. Zhang L; Zhang Y; Li N; Xu F; Pan ZK; Guan ZZ Ai Zheng; 2004 Nov; 23(11 Suppl):1455-8. PubMed ID: 15566656 [TBL] [Abstract][Full Text] [Related]
25. Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: a phase II study. Lilenbaum R; Cano R; Schwartz M; Siegel L; Lutzky J; Lewis M; Krill E; Barreras L; Davila E Cancer; 2000 Feb; 88(3):557-62. PubMed ID: 10649247 [TBL] [Abstract][Full Text] [Related]
26. Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study. Gagel B; Piroth M; Pinkawa M; Reinartz P; Krohn T; Kaiser HJ; Stanzel S; Breuer C; Asadpour B; Schmachtenberg A; Eble MJ BMC Cancer; 2007 Jun; 7():112. PubMed ID: 17598906 [TBL] [Abstract][Full Text] [Related]
27. Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group. Comella P; Frasci G; Panza N; Manzione L; De Cataldis G; Cioffi R; Maiorino L; Micillo E; Lorusso V; Di Rienzo G; Filippelli G; Lamberti A; Natale M; Bilancia D; Nicolella G; Di Nota A; Comella G J Clin Oncol; 2000 Apr; 18(7):1451-7. PubMed ID: 10735892 [TBL] [Abstract][Full Text] [Related]
28. Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer. Han JY; Lee DH; Song JE; Lee SY; Kim HY; Kim HT; Lee JS Cancer; 2008 Jul; 113(2):388-95. PubMed ID: 18484595 [TBL] [Abstract][Full Text] [Related]
29. Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial. Bajetta E; Chiara Stani S; De Candis D; Bidoli P; Mariani L; Zilembo N; Pozzi P; Procopio G Cancer; 2000 Aug; 89(4):763-8. PubMed ID: 10951338 [TBL] [Abstract][Full Text] [Related]
30. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068 [TBL] [Abstract][Full Text] [Related]
31. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group. Comella P; Frasci G; Panza N; Manzione L; Lorusso V; Di Rienzo G; Cioffi R; De Cataldis G; Maiorino L; Bilancia D; Nicolella G; Natale M; Carpagnano F; Pacilio C; De Lena M; Bianco A; Comella G J Clin Oncol; 1999 May; 17(5):1526-34. PubMed ID: 10334540 [TBL] [Abstract][Full Text] [Related]
32. Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). Boni C; Tiseo M; Boni L; Baldini E; Recchia F; Barone C; Grossi F; Germano D; Matano E; Marini G; Labianca R; Di Costanzo F; Bagnulo A; Pennucci C; Caroti C; Mencoboni M; Zanelli F; Prochilo T; Cafferata MA; Ardizzoni A; Br J Cancer; 2012 Feb; 106(4):658-65. PubMed ID: 22240782 [TBL] [Abstract][Full Text] [Related]
33. Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer. Isokangas OP; Knuuttila A; Halme M; Mäntylä M; Lindström I; Nikkanen V; Viren M; Joensuu H; Mattson K Ann Oncol; 1999 Sep; 10(9):1059-63. PubMed ID: 10572603 [TBL] [Abstract][Full Text] [Related]
34. Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer. Esteban E; Fra J; Sala M; Carrasco J; Corral N; Vieitez JM; Estrada E; Palacio I; Buesa JM; Lacave AJ Invest New Drugs; 2002 Aug; 20(3):317-26. PubMed ID: 12201494 [TBL] [Abstract][Full Text] [Related]
35. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer. Lorusso V; Carpagnano F; Frasci G; Panza N; Di Rienzo G; Cisternino ML; Napoli G; Orlando S; Cinieri S; Brunetti C; Palazzo S; De Lena M J Clin Oncol; 2000 Jan; 18(2):405-11. PubMed ID: 10637256 [TBL] [Abstract][Full Text] [Related]
36. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. Gridelli C; Perrone F; Gallo C; Cigolari S; Rossi A; Piantedosi F; Barbera S; Ferraù F; Piazza E; Rosetti F; Clerici M; Bertetto O; Robbiati SF; Frontini L; Sacco C; Castiglione F; Favaretto A; Novello S; Migliorino MR; Gasparini G; Galetta D; Iaffaioli RV; Gebbia V; J Natl Cancer Inst; 2003 Mar; 95(5):362-72. PubMed ID: 12618501 [TBL] [Abstract][Full Text] [Related]
37. Randomized phase II study of carboplatin/gemcitabine versus vinorelbine/gemcitabine in patients with advanced nonsmall cell lung cancer: West Japan Thoracic Oncology Group (WJTOG) 0104. Yamamoto N; Nakagawa K; Uejima H; Sugiura T; Takada Y; Negoro S; Matsui K; Kashii T; Takada M; Nakanishi Y; Kato T; Fukuoka M; Cancer; 2006 Aug; 107(3):599-605. PubMed ID: 16804877 [TBL] [Abstract][Full Text] [Related]
38. Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin. Pujol JL; Breton JL; Gervais R; Rebattu P; Depierre A; Morère JF; Milleron B; Debieuvre D; Castéra D; Souquet PJ; Moro-Sibilot D; Lemarié E; Kessler R; Janicot H; Braun D; Spaeth D; Quantin X; Clary C Ann Oncol; 2005 Apr; 16(4):602-10. PubMed ID: 15741225 [TBL] [Abstract][Full Text] [Related]
39. Options in advanced non-small cell lung cancer: a review and report on a phase II study of vinorelbine plus gemcitabine. Lilenbaum R Oncologist; 2001; 6 Suppl 1():16-9. PubMed ID: 11182000 [TBL] [Abstract][Full Text] [Related]
40. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. Gridelli C; Cigolari S; Gallo C; Manzione L; Ianniello GP; Frontini L; Ferraù F; Robbiati SF; Adamo V; Gasparini G; Novello S; Perrone F; Lung Cancer; 2001; 31(2-3):277-84. PubMed ID: 11165408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]